Market Place
Sourcing Support
Tarveda Therapeutics Announces Data from Phase 2 Trial of PEN-221
01 Nov 2021 //
BUSINESSWIRE
Tarveda and SciClone expand License Agreement for HSP90-PI3K Drug Conjugates
16 Sep 2021 //
BUSINESSWIRE
Tarveda to Present Data from Phase 2 Study of PEN-221 at ASCO Meeting
20 May 2021 //
BIOSPACE
Tarveda Therapeutics Publishes Preclinical Study Evaluating HSP90
04 Aug 2020 //
BUSINESSWIRE
Tarveda Therapeutics Publishes Preclinical Study Evaluating HSP90 Binding
04 Aug 2020 //
BUSINESSWIRE
Tarveda Therapeutics Reports Complete Data from of Ph 1/2a Study of PEN-866
13 May 2020 //
BUSINESSWIRE
Tarveda Therapeutics Presents Pharmacokinetic & Tumor Biopsy Data PEN-866
27 Apr 2020 //
BUSINESSWIRE
Tarveda Therapeutics Presents Pharmacokinetic and Tumor Biopsy Data PEN-866
27 Apr 2020 //
TARVEDATX
Tarveda Therapeutics Provides Update on Proposed Merger with Organovo
07 Apr 2020 //
BUSINESSWIRE
Tarveda Therapeutics Provides Update on Proposed Merger with Organovo
07 Apr 2020 //
BUSINESSWIRE
Organovo and Tarveda Therapeutics Announce Definitive Merger Agreement
18 Dec 2019 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.